Upregulation of ITGAV and the underlying mechanisms in nasopharyngeal carcinoma

Upregulation of ITGAV and the underlying mechanisms in nasopharyngeal carcinoma

Background: Integrin subunit α -v (ITGAV) has been demonstrated to be dysregulated and involved in cancer promotion processes in a variety of cancers, but studies on nasopharyngeal carcinoma (NPC) have been limited. Our study aimed to comprehensively assess the expression level and potential mechani...

Full description

Bibliographic Details
Main Authors:	Si-Wei Huang, Jia-Yuan Luo, Li-Ting Qin, Su-Ning Huang, Zhi-Guang Huang, Yi-Wu Dang, Juan He, Jiang-Hui Zeng, Zhu-Xin Wei, Wei Lu, Gang Chen
Format:	Article
Language:	English
Published:	Elsevier 2022-11-01
Series:	Electronic Journal of Biotechnology
Subjects:	BRCA1 Breast cancer Cancer Cell cycle Gene chip Integrin
Online Access:	http://www.sciencedirect.com/science/article/pii/S0717345822000367

Similar Items

ITGAV Promotes the Progression of Head and Neck Squamous Cell Carcinoma
by: Lingyi Xu, et al.
Published: (2024-03-01)

WDHD1 is over‐expressed in nasopharyngeal carcinoma and may control the expression of ITGAV
by: Ji‐Yun Wu, et al.
Published: (2023-01-01)

Overexpression of Integrin alpha V (ITGAV) in gastric cancer and its prognostic significance
by: Wen Zhang, et al.
Published: (2023-12-01)

A study of The Frequency and Type of Mutation in Exon 11 in BRCA1 and BRCA2 Genes In Breast Cancer Women With Positive Family History
by: Noor Jassim M, et al.
Published: (2018-06-01)

A study of The Frequency and Type of Mutation in Exon 11 in BRCA1 and BRCA2 Genes In Breast Cancer Women With Positive Family History
by: Noor Jassim M, et al.
Published: (2018-06-01)

Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women
by: Wen-Ming Cao, et al.
Published: (2019-06-01)

Gynecologic and breast cancers with hereditary cancer predisposition syndromes
by: Courtney F. Connelly, et al.
Published: (2024-11-01)

Acceptance of, inclination for, and barriers in genetic testing for gene mutations that increase the risk of breast and ovarian cancers among female residents of Warsaw
by: Dominik Olejniczak, et al.
Published: (2016-03-01)

Germline mutation landscape of Chinese patients with familial breast/ovarian cancer in a panel of 22 susceptibility genes
by: Jiayu Wang, et al.
Published: (2019-05-01)

BRCA2 mutations in familial breast cancer with prostate cancer: a case report and literature review
by: Zhengsheng Liu, et al.
Published: (2024-09-01)

Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer
by: Anna Öfverholm, et al.
Published: (2023-08-01)

BRCA1, BRCA2 mutations — future of predictive oncology: a review of literature
by: V. N. Dmitriev, et al.
Published: (2014-07-01)

Impact of BRCA1/2 germline mutation on the incidence of second primary cancer following postoperative radiotherapy in patients with triple-negative breast cancer
by: HU Xiaoyu, CAI Yuwen, YE Fugui, SHAO Zhimin, HU Weigang, YU Keda
Published: (2024-02-01)

BRCA1 and BRCA2 Genetic Testing in Breast and/or Ovarian Cancer Families in Iran
by: Fatemeh Keshavarzi, et al.
Published: (2010-01-01)

The Landscape of BRCA Mutations among Egyptian Women with Breast Cancer
by: Hamdy A. Azim, et al.
Published: (2023-09-01)

Do we know properly young age breast cancer patients: a double centre study
by: Hale Onder Yilmaz, et al.
Published: (2021-06-01)

Genetic testing for hereditary breast cancer in Poland: 1998–2022
by: Jacek Gronwald, et al.
Published: (2023-06-01)

BRCA1 and BRCA2 mutations in Iranian breast cancer patients: A systematic review
by: Hossein Neamatzadeh, et al.
Published: (2015-01-01)

The scaffold of neutrophil extracellular traps promotes CCA progression and modulates angiogenesis via ITGAV/NFκB
by: Congyi Zhang, et al.
Published: (2024-02-01)

Choices for cancer prevention for women with a BRCA1 mutation? a personal view
by: Steven A. Narod
Published: (2023-11-01)

BRCA1 mutations in Brazilian patients
by: Juliano Javert Lourenço, et al.
Published: (2004-01-01)

Metastatic colorectal cancer as the primary phenotype in a hereditary breast and ovarian cancer patient with Germline BRCA1 mutation: a case report
by: Ying Liu, et al.
Published: (2022-12-01)

Risk of metastasis in BRCA2 carriers diagnosed with triple‐negative breast cancer
by: Marcelo Moreno, et al.
Published: (2023-08-01)

Breast cancer in a male patient with a BRCA1 mutation - a case report
by: Piotr Krajewski, et al.
Published: (2018-09-01)

BRCA1 gene expression in relation to prognostic parameters of breast cancer
by: Manal Kamal, et al.
Published: (2011-09-01)

Breast cancer in a male patient with a BRCA1 mutation - a case report
by: Piotr Krajewski, et al.
Published: (2018-09-01)

Hereditary female cancers: Breast, ovarian, and endometrial
by: J. Morgan Tucker, III, et al.
Published: (2011-12-01)

Detection of BRCA1and BRCA2 mutation for Breast Cancer in Sample of Iraqi Women above 40 Years
by: Baghdad Science Journal
Published: (2010-03-01)

Ethnic aspects of hereditary breast cancer
by: P. A. Gervas, et al.
Published: (2019-04-01)

BRCA2 carriers with male breast cancer show elevated tumour methylation
by: Siddhartha Deb, et al.
Published: (2017-09-01)

Triple-negative breast cancer arising in a fibroadenoma in BRCA 1 mutated patient
by: Nicole Brunetti, et al.
Published: (2023-01-01)

BRCA1 & BRCA2 methylation as a prognostic and predictive biomarker in cancer: Implementation in liquid biopsy in the era of precision medicine
by: Maria Panagopoulou, et al.
Published: (2024-12-01)

Age-specific breast and ovarian cancer risks associated with germline BRCA1 or BRCA2 pathogenic variants – an Asian study of 572 familiesResearch in context
by: Weang-Kee Ho, et al.
Published: (2024-03-01)

Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer
by: Alice Gambelli, et al.
Published: (2024-04-01)

Role of BRCA 1 и BRCA 2 gene mutations in the occurrence of male breast cancer
by: A. V. Bykova, et al.
Published: (2014-07-01)

BRCA1/2 mutations in Swiss patients with familial or early-onset breast and ovarian cancer
by: F Schoumacher, et al.
Published: (2001-04-01)

Different Mechanisms in Doxorubicin-Induced Cardiomyopathy: Impact of BRCA1 and BRCA2 Mutations
by: Hien C. Nguyen, et al.
Published: (2024-01-01)

BRCA testing and management of BRCA-mutated early-stage breast cancer: a comprehensive statement by expert group from GCC region
by: Humaid O. Al-Shamsi, et al.
Published: (2024-04-01)

Increased prevalence of the founder BRCA1 c.5309G>T and recurrent BRCA2 c.1310_1313delAAGA mutations in breast cancer families from Northerstern region of Morocco: evidence of geographical specificity and high relevance for genetic counseling
by: Rahma Melki, et al.
Published: (2023-04-01)

Prevalence of 185delAG and 5382insC mutations in BRCA1, and 6174delT in BRCA2 in women of Ashkenazi Jewish origin in southern Brazil
by: Crisle Vignol Dillenburg, et al.
Published: (2012-01-01)